| Pharmaceutical Information |
| Drug Name |
Hydrocortisone cypionate |
| Drug ID |
BADD_D01089 |
| Description |
Not Available |
| Indications and Usage |
For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB14541
|
| KEGG ID |
D00976
|
| MeSH ID |
C029109
|
| PubChem ID |
223253
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
4XDY25L70B
|
| Synonyms |
hydrocortisone cypionate | hydrocortisone 21-cyclopentylpropionate |
|
| Chemical Information |
| Molecular Formula |
C29H42O6 |
| CAS Registry Number |
508-99-6 |
| SMILES |
CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)COC(=O)CCC5CCCC5)O)C)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
